EUVIMEDEUVIMED entdecken
Open Access

Characterization of growth factors in platelet-poor plasma for eye drop applications from umbilical cord blood and from allogeneic adult donor serum.

Larysa Mykhailova, Dinara Samarkanova, Jesus Fernandez-Sojo, Stefania Villa, Manuela Brasca, Paolo Rebulla, Daniele Prati, Tiziana Montemurro

Blood transfusion · 01.09.2026 · 24 (5) · 425-429

DOI: 10.2450/bloodtransfus.1330 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood transfusion, erschienen am 01.09.2026. Verfasst von Larysa Mykhailova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background - Serum eye drops obtained after the coagulation of platelet-rich, adult donor blood (AB-S) are currently used to promote corneal healing in dry eye disease (DED). Recently, unique immunomodulatory factors that could prove clinically useful in DED have been identified in platelet-poor plasma from cord blood (CB-PPP). In this descriptive, non-comparative pre-clinical study, we determined the growth factor (GF) content in CB-PPP and AB-S to expand the current knowledge on the clinical potential of blood derived eye drops. Materials and methods - CB-PPP (No.=20) was prepared from anticoagulated CB by differential centrifugation using commercial BioNest ABC kits. AB-S (No.=6) was prepared from clotted 450 mL blood collections using commercial transfer bags. Epidermal growth factor (EGF), vascular endothelial growth factor (VEGF), fibroblast growth factor (bFGF), platelet derived growth factor isoforms (PDGF-AA, -AB, -BB) were quantified by Luminex technology. Results - Median EGF, VEGF and PDGF-AA, -AB and -BB (pg/mL) were lower in CB-PPP than in AB-S: 5.45 vs 224.0; 35.83 vs 401.26; 362.05 vs 2480.44; 197.06 vs 624.14; 1097.11 vs 2836.29, respectively. Conversely, median bFGF was about 9-fold higher in CB-PPP than in AB-S: 10.07 vs 1.13. High variability was observed between individual samples. Discussion - This study expands current knowledge on blood-derived products for ophthalmic applications. The observed high inter-sample GF variability requires the development of standard procedures of unit pooling in view of clinical applications.

Schlagwörter

platelet-poor plasmaumbilical cord bloodgrowth factorseye dropsdry eyecorneal wound healingepidermal growth factorvascular endothelial growth factorbasic fibroblast growth factorplatelet-derived growth factor

Autor:innen und Institutionen

  • Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Instituto de Investigación Sanitaria Hospital Universitari Vall d'Hebron Barcelona, Spain.
  • Cord Blood Bank Programa Concordia Banc de Sang i Teixits, Barcelona, Spain.
  • Milano Cord Blood Bank, Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Italy.

Zitieren

APA

Mykhailova, L., Samarkanova, D., Fernandez-Sojo, J., Villa, S., Brasca, M., Rebulla, P., Prati, D., & Montemurro, T. (2026). Characterization of growth factors in platelet-poor plasma for eye drop applications from umbilical cord blood and from allogeneic adult donor serum. Blood transfusion, 24(5), 425-429. https://doi.org/10.2450/bloodtransfus.1330

Vancouver

Mykhailova L, Samarkanova D, Fernandez-Sojo J, Villa S, Brasca M, Rebulla P, et al. Characterization of growth factors in platelet-poor plasma for eye drop applications from umbilical cord blood and from allogeneic adult donor serum. Blood transfusion. 2026;24(5):425-429. doi:10.2450/bloodtransfus.1330

BibTeX
@article{Mykhailova2026,
  author = {Mykhailova, Larysa and Samarkanova, Dinara and Fernandez-Sojo, Jesus and Villa, Stefania and Brasca, Manuela and Rebulla, Paolo and Prati, Daniele and Montemurro, Tiziana},
  title = {Characterization of growth factors in platelet-poor plasma for eye drop applications from umbilical cord blood and from allogeneic adult donor serum},
  journal = {Blood transfusion},
  year = {2026},
  volume = {24},
  number = {5},
  pages = {425--429},
  doi = {10.2450/bloodtransfus.1330}
}
Kostenlos starten →